| 000 | 00876nam a2200265Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20220926033943.0 | ||
| 006 | a|||||r|||| 00| 0 | ||
| 007 | ta | ||
| 008 | 220923b |||||||| |||| 00| 0 eng d | ||
| 020 | _a08474731676 | ||
| 037 | _cGeneral Book | ||
| 040 |
_aRTL _cRTL _beng |
||
| 041 |
_2eng _aeng |
||
| 082 | _aX9(F56):75.73.N7, L5 | ||
| 100 |
_aWardell William M _9339852 |
||
| 245 | 0 | _aRegulation and drug development | |
| 260 |
_aWashingon _bAmerican Enterprise Institute For public Policy Research _c1967 |
||
| 300 |
_a181p. _ccm. |
||
| 490 | _aAmerican Enterprise Institute For public Policy Research , Evaluative Studies | ||
| 650 |
_aPharmaceutical Industry _9230534 |
||
| 700 |
_a Lasagna Louis _9339853 |
||
| 942 |
_hX9(F56):75.73.N7, L5 _cGB _2CC |
||
| 999 |
_c658447 _d658447 |
||